Description:
Targets DNMT1 in cancer treatment.

Text:
Successful examples can be found in cancer research, with the 
approval of eight epigenetic drugs (drugs targeting epigenetic proteins) for clinical use 
azacytidine and decitabine targeting DNMT1, vorinostat, belinostat, panobinostat, romidepsin
